Merlin E, Hequet O, Kanold J
Apheresis Unit, Service d'Hémato-Oncologie et Thérapie Cellulaire Pédiatrique, Centre Hospitalier Universitaire, Clermont-Ferrand, France.
Apheresis Unit, Etablissement Français du Sang Rhône Alpes, Centre Hospitalier Lyon Sud Pierre Bénite, France.
Transfus Apher Sci. 2019 Apr;58(2):136-141. doi: 10.1016/j.transci.2019.03.006. Epub 2019 Mar 13.
Automatic red blood cell exchange i.e. using devices (RBCX) has become a standard therapy to remove abnormal red blood cells (RBC) in adults and children affected by sickle cell disease (SCD). This treatment is performed both in emergency to treat acute complications and through a regular program of RBCX to prevent the recurrence of complications. However, small children, i.e. those with a low body weight, height and total blood volume, are at risk of relative hypovolemia and metabolic complications during the procedure. Moreover, the peripheral venous access is limited among young children, which requires alternative short- or long-term venous access. These two main limiting factors necessitate adaptations of the procedures and subsequent monitoring during and after the sessions. However, performing RBCX in children requires other adaptations and cautions that must be considered. Our review summarizes the limits, safety precautions and the adaptations of the techniques to ensure RBCX in children.
自动红细胞置换,即使用设备进行红细胞置换(RBCX),已成为治疗患有镰状细胞病(SCD)的成人和儿童异常红细胞(RBC)的标准疗法。这种治疗既在紧急情况下用于治疗急性并发症,也通过定期的红细胞置换计划来预防并发症的复发。然而,幼儿,即体重、身高和血容量较低的儿童,在该过程中存在相对血容量不足和代谢并发症的风险。此外,幼儿的外周静脉通路有限,这需要替代的短期或长期静脉通路。这两个主要限制因素使得在治疗期间及之后需要对操作过程及其后续监测进行调整。然而,对儿童进行红细胞置换还需要考虑其他调整和注意事项。我们的综述总结了确保儿童红细胞置换的限制、安全预防措施和技术调整。